Procter & Gamble Stock Forecast for 2023 - 2025 - 2030
Updated on 05/28/2023
Procter & Gamble Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Procter & Gamble were recently set by twelve distinguished experts, with an average mark of $155.50. If it reached this goal, it would represent a potential upside of approximately 6.95% from the previous closing price in May, 2023. The high end is $170.00, and the low is $126.00. If you are interested in PG stock, you should also look at its competitors.
6.95% Upside
Procter & Gamble Fair Value Forecast for 2023 - 2025 - 2030
Procter & Gamble's Price has grown In the last three years, rising from $107.21 to $142.32 – a growth of 32.74%. In the next year, analysts believe that Fair Value will reach $148.49 – an increase of 4.33%. For the next eight years, experts predict that Procter & Gamble's Fair Value will grow at a rate of 56.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
10
|
$154.35 | Buy/Sell | $178.79 | 16.94% |
| ABBV Stock Forecast | AbbVie | Outperform |
10
|
$137.56 | Buy/Sell | $162.24 | 19.95% |
| COST Stock Forecast | Costco Wholesale Corp | Outperform |
13
|
$507.26 | Buy/Sell | $547.19 | 7.93% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
10
|
$102.87 | Buy/Sell | $122.59 | 21.51% |
| MO Stock Forecast | Altria Group | Hold |
7
|
$44.61 | Buy/Sell | $49.69 | 10.96% |
Procter & Gamble Revenue Forecast for 2023 - 2025 - 2030
Procter & Gamble's Revenue has grown In the last three years, rising from $67.68B to $80.19B – a growth of 18.47%. In the next year, analysts believe that Revenue will reach $82.95B – an increase of 3.45%. For the next eight years, experts predict that Procter & Gamble's Revenue will grow at a rate of 33.10%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSK Stock Forecast | GSK | Outperform |
16
|
£1.39k | Buy/Sell | £16.95 | -98.84% |
| KER Stock Forecast | Kering | Outperform |
18
|
527.60€ | Buy/Sell | 621.06€ | 17.51% |
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$76.21 | Buy/Sell | $81.35 | 7.60% |
.jpg)
Procter & Gamble Dividend per Share Forecast for 2023 - 2025 - 2030
Procter & Gamble's Dividend per Share has seen impressive growth In the last three years, rising from $2.90 to $3.65 – a growth of 25.86%. In the next year, analysts believe that Dividend per Share will reach $3.71 – an increase of 1.64%. For the next eight years, the forecast is for Dividend per Share to grow by 61.64%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAYN Stock Forecast | Bayer | Outperform |
7
|
54.40€ | Buy/Sell | 74.54€ | 38.79% |
| GIS Stock Forecast | General Mills Inc | Hold |
16
|
$84.18 | Buy/Sell | $81.79 | -2.59% |
| KMB Stock Forecast | Kimberly-Clark Corp | Hold |
16
|
$136.30 | Buy/Sell | $131.81 | -4.99% |
Procter & Gamble Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Procter & Gamble's Free Cash Flow has grown, moving from $11.90B to $13.65B – an increase of 14.77%. In the next year, analysts predict that Free Cash Flow will jump to $15.74B – up 15.28% from the current level. Looking ahead to eight years, experts forecast that Free Cash Flow will grow by 56.92%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ECL Stock Forecast | Ecolab Inc | Outperform |
18
|
$166.91 | Buy/Sell | $164.25 | -1.14% |
| ALC Stock Forecast | Alcon | Outperform |
15
|
CHF66.18 | Buy/Sell | CHF0.00 | 30.51% |
| BN Stock Forecast | Danone | Hold |
18
|
49.65€ | Buy/Sell | 55.47€ | 11.78% |
Procter & Gamble Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Procter & Gamble's Net Income has grown by 279.60%, rising from $3.90B to $14.79B. For the next year, analysts predict that Net Income will reach $15.66B – an increase of 5.86%. Over the next eight years, experts believe that Procter & Gamble's Net Income will grow at a rate of 40.77%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
16
|
76.28€ | Buy/Sell | 65.97€ | -12.82% |
| COLO B Stock Forecast | Coloplast A/S | Hold |
18
|
kr848.20 | Buy/Sell | kr1.05k | 21.43% |
| K Stock Forecast | Kellogg Co | Hold |
13
|
$67.67 | Buy/Sell | $73.45 | 9.35% |
Procter & Gamble EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Procter & Gamble's EBITDA has seen an increase, rising from $16.66B to $21.24B. This represents a growth of 27.53%. Analysts predict that Procter & Gamble's EBITDA will increase in the upcoming year, reaching $22.25B. This would represent an increase of 4.76%. Over the next eight years, experts predict that Procter & Gamble's EBITDA will grow at a rate of 41.19%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CHD Stock Forecast | Church & Dwight Co Inc | Hold |
11
|
$93.97 | Buy/Sell | $82.17 | -9.55% |
| CPB Stock Forecast | Campbell Soup | Hold |
16
|
$51.51 | Buy/Sell | $52.53 | 2.89% |
| 4452 Stock Forecast | Kao | Outperform |
18
|
¥5.11k | Buy/Sell | ¥0.00 | 17.53% |
Procter & Gamble EBIT Forecast for 2023 - 2025 - 2030
Procter & Gamble's EBIT has seen growth In the last three years, going from $13.83B to $17.81B – a gain of 28.78% In the next year, analysts believe that EBIT will reach $19.19B – an increase of 7.72%. For the next eight years, the forecast is forEBIT to grow by 47.53%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PHIA Stock Forecast | Koninklijke Philips N.V. | Outperform |
18
|
15.33€ | Buy/Sell | 50.07€ | 98.96% |
| CA Stock Forecast | Carrefour | Outperform |
18
|
16.02€ | Buy/Sell | 19.86€ | 20.47% |
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
96.70€ | Buy/Sell | 105.55€ | 11.17% |
Procter & Gamble EPS Price Prediction Forecast for 2023 - 2025 - 2030
Procter & Gamble's EPS has grown In the last three years, rising from $4.52 to $6.00 – a growth of 32.74%. In the next year, analysts believe that EPS will reach $6.26 – an increase of 4.33%. For the next eight years, experts predict that Procter & Gamble's EPS will grow at a rate of 56.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BBWI Stock Forecast | Bath & Body Works | Outperform |
15
|
$36.89 | Buy/Sell | $51.40 | 32.83% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Outperform |
18
|
Rp4.27k | Buy/Sell | Rp5.47k | 15.97% |
| A090430 Stock Forecast | Amorepacific | Outperform |
18
|
₩137.50k | Buy/Sell | ₩269.69k | 52.36% |
Site Navigation
.jpg)